{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T10:34:35.156841+00:00","published_at":"2026-10-17T04:46:43.578776+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1igw1entwkrhh","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:timothy-coughlin","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Timothy Coughlin seat on ADC Therapeutics SA, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:n6axrj11wt8hp","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:committee:adc-therapeutics-sa:audit-chair","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Audit · Chair committee of ADC Therapeutics SA, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:s34i2n30yhtn","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:timothy-coughlin","alpha:committee:adc-therapeutics-sa:audit-chair"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Timothy Coughlin member of Audit · Chair, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:c5y4jp1a39uvt","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:robert-azelby","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Robert Azelby seat on ADC Therapeutics SA, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:5ja545edkv95","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:committee:adc-therapeutics-sa:audit-compensation","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Audit; Compensation committee of ADC Therapeutics SA, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:z4u4xm16texwe","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:robert-azelby","alpha:committee:adc-therapeutics-sa:audit-compensation"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Robert Azelby member of Audit; Compensation, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:sx1vxn1mltseh","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:ameet-mallik","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Ameet Mallik seat on ADC Therapeutics SA, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1xlozu61d90436","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:jean-pierre-bizzari","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Jean-Pierre Bizzari seat on ADC Therapeutics SA, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:8jjde1jti3g2","event_type":"COMMITTEE_CREATED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:committee:adc-therapeutics-sa:nominating-and-governance-chair","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Nominating and Governance · Chair committee of ADC Therapeutics SA, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1k3ceywrmb6pe","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:jean-pierre-bizzari","alpha:committee:adc-therapeutics-sa:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Jean-Pierre Bizzari member of Nominating and Governance · Chair, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:20yzxgvbm5qw","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:viviane-monges","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Viviane Monges seat on ADC Therapeutics SA, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2xr9u2lz8u90","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:committee:adc-therapeutics-sa:audit-nominating-and-governance","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Audit; Nominating and Governance committee of ADC Therapeutics SA, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:19dk430qb7ouw","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:viviane-monges","alpha:committee:adc-therapeutics-sa:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Viviane Monges member of Audit; Nominating and Governance, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:rtmxrnpo4ydl","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:ron-squarer","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Ron Squarer seat on ADC Therapeutics SA, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2mz3e21qwnh2","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:victor-sandor","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Victor Sandor seat on ADC Therapeutics SA, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ljkmjk1gle01y","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:peter-hug","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Peter Hug seat on ADC Therapeutics SA, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:a3rar214sbmpe","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:committee:adc-therapeutics-sa:compensation-chair-nominating-and-governance","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Compensation · Chair; Nominating and Governance committee of ADC Therapeutics SA, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3rv73n1nrq1k7","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:peter-hug","alpha:committee:adc-therapeutics-sa:compensation-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Peter Hug member of Compensation · Chair; Nominating and Governance, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:12h8fn2hcx13c","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:tyrell-j-rivers","alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df"],"caused_claim_ids":["alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d"],"summary":"Tyrell J. Rivers seat on ADC Therapeutics SA, effective 2018-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:7","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ameet-mallik","object_label":"Ameet Mallik","object_source_name_forms":[],"value":"Ameet Mallik: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ameet-mallik","name":"Ameet Mallik"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jean-pierre-bizzari","object_label":"Jean-Pierre Bizzari","object_source_name_forms":[],"value":"Jean-Pierre Bizzari: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jean-pierre-bizzari","name":"Jean-Pierre Bizzari"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-hug","object_label":"Peter Hug","object_source_name_forms":[],"value":"Peter Hug: Director, Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-hug","name":"Peter Hug"},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robert-azelby","object_label":"Robert Azelby","object_source_name_forms":[],"value":"Robert Azelby: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:robert-azelby","name":"Robert Azelby"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:14","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ron-squarer","object_label":"Ron Squarer","object_source_name_forms":[],"value":"Ron Squarer: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ron-squarer","name":"Ron Squarer"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:timothy-coughlin","object_label":"Timothy Coughlin","object_source_name_forms":[],"value":"Timothy Coughlin: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:timothy-coughlin","name":"Timothy Coughlin"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:16","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tyrell-j-rivers","object_label":"Tyrell J. Rivers","object_source_name_forms":[],"value":"Tyrell J. Rivers: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tyrell-j-rivers","name":"Tyrell J. Rivers"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:17","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:victor-sandor","object_label":"Victor Sandor","object_source_name_forms":[],"value":"Victor Sandor: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:victor-sandor","name":"Victor Sandor"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18","subject_id":"alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:viviane-monges","object_label":"Viviane Monges","object_source_name_forms":[],"value":"Viviane Monges: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:viviane-monges","name":"Viviane Monges"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ADC Therapeutics SA DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-24T15:46:02.182+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.827,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.87,"cross_source_agreement":0.75,"temporal_completeness":0.429},"diagnostics":{"published_claims":30,"factual_claims":30,"claims_with_linked_evidence":30,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":21,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:43.578776+00:00","observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":"2026-10-17T04:46:43.578776+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":30,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/adc-therapeutics-sa/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}